[go: up one dir, main page]

BRPI0511133A - uso de galacto-oligossacarìdeos e polifrutose - Google Patents

uso de galacto-oligossacarìdeos e polifrutose

Info

Publication number
BRPI0511133A
BRPI0511133A BRPI0511133-1A BRPI0511133A BRPI0511133A BR PI0511133 A BRPI0511133 A BR PI0511133A BR PI0511133 A BRPI0511133 A BR PI0511133A BR PI0511133 A BRPI0511133 A BR PI0511133A
Authority
BR
Brazil
Prior art keywords
polyfructose
galactooligosaccharides
prebiotics
gos
compositions
Prior art date
Application number
BRPI0511133-1A
Other languages
English (en)
Inventor
Gelske Speelmans
Maria Johanna Adriana P Govers
Jan Knol
Eric Alexander Franciscus Tol
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0511133(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0511133A publication Critical patent/BRPI0511133A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Dairy Products (AREA)

Abstract

USO DE GALACTO-OLIGOSSACARìDEOS E POLIFRUTOSE A presente invenção refere-se ao campo de prebióticos. São providos usos para composições compreendendo quantidades sinergicamente eficazes de polifrutose e galactooligossacarídeos (GOS).
BRPI0511133-1A 2004-05-17 2005-05-17 uso de galacto-oligossacarìdeos e polifrutose BRPI0511133A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076479A EP1597978A1 (en) 2004-05-17 2004-05-17 Synergism of GOS and polyfructose
PCT/NL2005/000372 WO2005110121A1 (en) 2004-05-17 2005-05-17 Synergism of gos and polyfructose

Publications (1)

Publication Number Publication Date
BRPI0511133A true BRPI0511133A (pt) 2007-11-27

Family

ID=34928228

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511133-1A BRPI0511133A (pt) 2004-05-17 2005-05-17 uso de galacto-oligossacarìdeos e polifrutose

Country Status (20)

Country Link
US (5) US20100069320A1 (pt)
EP (10) EP1597978A1 (pt)
JP (2) JP5705400B2 (pt)
CN (6) CN1964638B (pt)
AT (2) ATE440506T1 (pt)
AU (2) AU2005244321B2 (pt)
BR (1) BRPI0511133A (pt)
CA (1) CA2565421C (pt)
CY (2) CY1110425T1 (pt)
DE (2) DE602005016319D1 (pt)
DK (3) DK1685763T4 (pt)
ES (6) ES2314826T5 (pt)
HU (1) HUE046219T2 (pt)
NZ (2) NZ588306A (pt)
PL (6) PL1685763T5 (pt)
PT (2) PT1927292E (pt)
RU (1) RU2402929C2 (pt)
SI (2) SI1927292T1 (pt)
UA (1) UA91678C2 (pt)
WO (1) WO2005110121A1 (pt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
ATE373963T1 (de) * 2002-08-30 2007-10-15 Campina Bv Schäumender bestandteil und diesen bestandteil enthaltende produkte
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20080015166A1 (en) * 2004-06-22 2008-01-17 N.V. Nutricia Barrier Integrity in Hiv Patients
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
MX2007013075A (es) * 2005-04-21 2008-01-11 Nutricia Nv Suplemento nutritivo para pacientes con vih.
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007105945A2 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
WO2008015374A2 (en) 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
DE102006055210A1 (de) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Ｄｆａｉｉｉの製造方法及びｄｆａｉｉｉ高含有植物エキス
EP2185931B1 (en) 2007-09-07 2013-07-10 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110034407A1 (en) 2007-12-21 2011-02-10 N. V. Nutricia Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2098124A1 (en) 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
RU2500408C2 (ru) * 2008-06-06 2013-12-10 Н.В. Нютрисиа Способ предотвращения использования кортикостероидов
PT2285387E (pt) * 2008-06-13 2016-02-09 Nutricia Nv Nutrição para a prevenção de infeções
WO2009151315A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
GB0906983D0 (en) 2009-04-23 2009-06-03 Clasado Inc Novel use
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
EP2813230A1 (en) 2009-07-15 2014-12-17 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing infections
DK3932410T3 (da) 2009-07-15 2024-09-23 Nutricia Nv Blanding af ikke-fordøjelige oligosaccharider til stimulering af immunsystemet
MX336032B (es) 2009-11-12 2016-01-07 Nestec Sa Composicion nutricional para promover el balance y salud de la microbiota intestinal.
AU2011234637B2 (en) * 2010-03-29 2013-08-29 Ferring B.V. A fast dissolving pharmaceutical composition
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
PL3097791T3 (pl) * 2010-06-04 2018-10-31 N.V. Nutricia Niestrawne oligosacharydy do doustnej indukcji tolerancji na białka pokarmowe
EP2452571A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of complementary infant/young child nutritional compositions
PH12013501382A1 (en) 2010-12-31 2013-09-02 Abbott Lab0Ratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
MX350782B (es) 2011-07-22 2017-09-18 Abbott Lab Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
RU2473347C1 (ru) * 2011-11-09 2013-01-27 Сергей Константинович Панюшин Композиция пребиотиков для нормализации микрофлоры организма
GB2511993B (en) * 2011-11-30 2019-09-18 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2013126015A1 (en) 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
WO2013172714A1 (en) 2012-05-18 2013-11-21 N.V. Nutricia Treatment of conditions associated with mycotoxin exposure
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
AU2014338690B2 (en) * 2013-10-25 2020-04-09 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
US11328621B2 (en) 2013-10-25 2022-05-10 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
CN103820314B (zh) * 2013-12-05 2016-05-11 南昌大学 一种模拟大肠酵解的装置及使用方法
US20170216328A1 (en) * 2014-04-04 2017-08-03 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
WO2016013928A1 (en) 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
MX2018007376A (es) * 2015-12-15 2018-12-06 Kuragobiotek Holdings S A P I De C V Una mezcla de probioticos y prebioticos mas nutrimentos en interaccion biologica y su uso para el tratamiento de la disbiosis intestinal en aves de corral, incrementar su respuesta inmunologica y factor de conversion.
US10751308B2 (en) 2016-01-26 2020-08-25 Societe Des Produits Nestle S.A. Composition for preventing or reducing transepidermal water loss
CN109561725A (zh) * 2016-06-10 2019-04-02 N·V·努特里奇亚 患过敏症的风险和用于降低该风险的营养物
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
EP3551194B1 (en) * 2016-12-06 2023-10-18 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
CN107198250B (zh) * 2017-05-23 2019-03-12 北京瑞千景科技发展有限公司 改善肠道微生态预防慢性病组合物和均衡营养食品及应用
WO2018215189A1 (en) 2017-05-24 2018-11-29 Nestec S.A. Hmos blends for use in infants or young children for health purposes
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
CN108117991B (zh) * 2017-11-03 2021-03-30 湖南海路生物科技有限公司 检测乙酸、异丁酸和/或戊酸含量的产品在制备揭示便秘患者的肠道微生态存在失衡的产品中的用途
EP3530743A1 (en) 2018-02-21 2019-08-28 Cambridge Glycoscience Ltd Method of production
JP7374991B2 (ja) 2018-08-15 2023-11-07 ケンブリッジ グリコサイエンス エルティーディー 新規組成物、それらの使用、およびそれらの形成方法
NL2021737B1 (en) * 2018-10-01 2020-05-07 Nutricia Nv Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
EP3646739A1 (en) 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
EP3968788A1 (en) 2019-05-17 2022-03-23 N.V. Nutricia Composition comprising vitamin a and non digestible oligosaccharides
CN114727642B (zh) 2019-08-16 2025-02-14 剑桥糖质科学有限公司 处理生物质以生产寡糖的方法和相关组合物
CN115279208B (zh) 2019-12-12 2024-12-17 剑桥糖质科学有限公司 低糖多相食品
AU2024309186A1 (en) 2023-06-28 2026-01-29 N.V. Nutricia Nutritional composition comprising urea, non-digestible oligosaccharide, and bifidobacteria

Family Cites Families (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US547952A (en) * 1895-10-15 Hayes
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
DE2033677A1 (de) 1970-07-07 1972-02-17 Deutsche Laevosan Gesellschaft C F Boehringer & Sohne GmbH & Co KG, Suddeutsche Zucker AG, 6800 Mannheim Arzneimittel
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (pt) * 1973-05-21 1981-10-29
JPS5342340A (en) 1976-09-29 1978-04-17 Shin Kobe Electric Machinery Method of producing battery plate
DE2844861A1 (de) 1978-10-14 1980-04-30 Kerstein Pharma Hameln Gmbh Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
US4859488A (en) 1987-09-15 1989-08-22 Kabushiki Kaisha Yakult Honsha Liquid food for curing constipation: polydextrose and oligosaccharide
DE3734962C1 (de) 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
ES2053953T3 (es) 1988-08-24 1994-08-01 Akzo Nv Uso de fracciones de heparina o fragmentos de heparina.
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
DE3901048A1 (de) 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
JPH02286058A (ja) 1989-04-28 1990-11-26 Nippon Synthetic Chem Ind Co Ltd:The 整腸剤
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
JP2731035B2 (ja) * 1991-01-24 1998-03-25 マーテック・コーポレイション 微生物油混合物およびその使用
FR2673812B1 (fr) 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9109125D0 (en) 1991-04-27 1991-06-12 Cerestar Holding Bv Sweetening composition
IT1248060B (it) 1991-06-14 1995-01-05 Italfarmaco Spa Eparine acilate come inibitori della replicazione di retrovirus
GB9116054D0 (en) 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
EP0593774B1 (en) 1992-04-10 1997-08-06 Otsuka Pharmaceutical Co., Ltd. Food composition which inhibits formation of intestinal putrefaction product
CA2089607C (en) 1992-11-05 1997-11-04 Ranjit K. Chandra Nutritional supplement for the elderly
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
GB9304746D0 (en) 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
US5472952A (en) 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
GB9318611D0 (en) 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
US5612320A (en) 1993-12-22 1997-03-18 Internutria, Inc. Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
DE4404877C1 (de) 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
ES2171535T3 (es) 1994-04-01 2002-09-16 Abbott Lab Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
DE69520528T2 (de) 1994-06-14 2001-09-27 Raffinerie Tirlemontoise, S.A. Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
JP3419897B2 (ja) 1994-07-22 2003-06-23 明治乳業株式会社 低アレルギー性調製乳
NL9401644A (nl) 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
EP0711503A3 (en) 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
JPH08151328A (ja) 1994-11-28 1996-06-11 Fuji Ratetsukusu Kk エイズ感染防止潤滑剤
IT1278166B1 (it) 1995-01-24 1997-11-17 Ars Ing Srl Processo per la preparazione di bis (2-idrossietil) teraftalato
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US6099871A (en) 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
JPH0965855A (ja) 1995-08-28 1997-03-11 Otsuka Shokuhin Kk 低カロリー整腸食品素材
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5968365A (en) 1996-02-05 1999-10-19 Mcneil-Ppc, Inc. Preparation of inulin products
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
CA2205773A1 (en) 1996-06-21 1997-12-21 Kraft Foods, Inc. Creamy, thick, hot beverage foam
DE69624805T3 (de) 1996-07-31 2007-01-04 Raffinerie Tirlemontoise, S.A. Fruktan- und/oder Polydextrose enthaltende Milchproduktpulver; Verfahren zu ihrer Herstellung und Verwendung derselben
FR2751876B1 (fr) * 1996-07-31 1998-12-31 Roc Sa Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
FR2752381B1 (fr) 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
JP3792309B2 (ja) 1996-08-30 2006-07-05 サントリー株式会社 不飽和脂肪酸含有油脂の製造方法
GB9619660D0 (en) 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
JPH10108647A (ja) 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
ATE233557T1 (de) 1996-11-05 2003-03-15 Wisconsin Alumni Res Found Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
AUPO430496A0 (en) 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
PL343902A1 (en) * 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
CN1253588A (zh) 1997-04-11 2000-05-17 艾博特公司 在植物中合成长链多不饱和脂肪酸的方法和组合物
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
DE19749122A1 (de) 1997-11-06 1999-06-10 Max Planck Gesellschaft Nucleinsäuremoleküle codierend Enzyme, die Fructosyltransferaseaktivität besitzen
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
GB9808579D0 (en) 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
EP0958825A1 (en) 1998-05-18 1999-11-24 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
FR2781673B1 (fr) 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6569488B2 (en) 1998-08-27 2003-05-27 Barnard Stewart Silver Processes for making novel inulin products
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
CN1226933C (zh) * 1999-01-28 2005-11-16 雀巢制品公司 加香可溶调白料粉
EP1074181A1 (en) 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
DE19940011B4 (de) 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
US6596302B2 (en) 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
EP1155627A1 (en) 2000-05-18 2001-11-21 Belovo Eggs & Egg Products Eggs with balanced lipid composition
DE10027050A1 (de) 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
WO2002018614A1 (en) 2000-08-30 2002-03-07 Amano Enzyme Inc. METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS
US20050238655A1 (en) 2004-01-06 2005-10-27 Paul Stamets Antiviral activity from medicinal mushrooms
US20020119928A1 (en) 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
WO2002060283A2 (en) 2001-01-30 2002-08-08 Unilever N.V. Food product comprising protein coated gas microbubbles
EP1228694A1 (en) 2001-02-02 2002-08-07 Societe Des Produits Nestle S.A. Aromatizing agent
CN1457357A (zh) * 2001-02-15 2003-11-19 旭电化工业株式会社 包含β－葡聚糖的制品
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
DE10136260B4 (de) 2001-07-25 2004-07-08 Südzucker AG Mannheim/Ochsenfurt Inulin in Geliermittelzusammensetzungen
NL1018832C2 (nl) 2001-08-27 2003-03-03 Friesland Brands Bv Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel.
WO2003027304A1 (en) * 2001-09-26 2003-04-03 Fuji Nihon Seito Corporation Processes for producing inulin
JP2003146887A (ja) 2001-11-07 2003-05-21 Gotoo Corporation:Kk Ｎｋ細胞活性化作用を有する製剤および飲食品
WO2003093322A2 (en) 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US6623954B1 (en) 2002-05-28 2003-09-23 Neose Technologies, Inc. Process for removal of phosphorous from a dairy stream
WO2004000042A2 (en) 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1374878A1 (en) * 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
ATE373963T1 (de) * 2002-08-30 2007-10-15 Campina Bv Schäumender bestandteil und diesen bestandteil enthaltende produkte
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
AU2003299034A1 (en) * 2002-09-20 2004-04-08 Griscom Bettle Iii Transdermal compositions
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
WO2004112508A1 (en) 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
EP1491570A1 (en) 2003-06-25 2004-12-29 DSM IP Assets B.V. Powder coating composition for low temperature cure
AU2003904192A0 (en) 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
CA2543626C (en) * 2003-10-24 2013-08-27 N.V. Nutricia Synbiotic composition for infants
EP1935425A3 (en) * 2003-10-24 2008-09-03 N.V. Nutricia Immunemodulating oligosaccharides for the treatment and/or prevention of chronic obstructive pulmonary disease (COPD)
FR2866203B1 (fr) 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US20080015166A1 (en) * 2004-06-22 2008-01-17 N.V. Nutricia Barrier Integrity in Hiv Patients
EP1721611A1 (en) 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1778857A4 (en) 2004-07-07 2007-09-26 Gen Hospital Corp Direct activation of atiii in whole blood and plasma
WO2006007676A1 (en) 2004-07-21 2006-01-26 Amazônia Fitomedicamentos Ltda. Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
JP4653465B2 (ja) 2004-10-25 2011-03-16 泰信 小林 ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
MX2007013075A (es) * 2005-04-21 2008-01-11 Nutricia Nv Suplemento nutritivo para pacientes con vih.
EP1916908A1 (en) 2005-07-27 2008-05-07 Cantabria Group LCC Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
ATE424756T1 (de) 2005-07-29 2009-03-15 Alcon Refractive Horizons Inc Seitenpositionierungssystem einer ophthalmischen vorrichtung und entsprechende verfahren
US20070231449A1 (en) 2006-03-30 2007-10-04 Nutracea Non-starchy rice bran polysaccharides
WO2009096772A1 (en) 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity

Also Published As

Publication number Publication date
CY1109673T1 (el) 2014-08-13
EP2266422B1 (en) 2019-08-21
PT1927292E (pt) 2010-01-04
ES2314826T5 (es) 2013-10-17
PL2266422T3 (pl) 2020-02-28
RU2006144870A (ru) 2008-06-27
EP3892117A1 (en) 2021-10-13
EP2263479A1 (en) 2010-12-22
EP1927292B1 (en) 2009-08-26
CN102090559A (zh) 2011-06-15
ES2583089T3 (es) 2016-09-19
AU2005244321B2 (en) 2010-08-19
EP2279671A1 (en) 2011-02-02
CN102090560A (zh) 2011-06-15
UA91678C2 (en) 2010-08-25
DK2266422T3 (da) 2019-11-25
EP2263478A1 (en) 2010-12-22
CN1964638A (zh) 2007-05-16
NZ588306A (en) 2012-04-27
WO2005110121A1 (en) 2005-11-24
PL1679980T3 (pl) 2016-11-30
EP1679980A1 (en) 2006-07-19
AU2010241530A1 (en) 2010-12-09
CN102008037A (zh) 2011-04-13
CA2565421C (en) 2014-07-15
ES2609300T3 (es) 2017-04-19
US20100069320A1 (en) 2010-03-18
CN102008036A (zh) 2011-04-13
CN102008035A (zh) 2011-04-13
CN102090559B (zh) 2013-01-30
EP1685763B2 (en) 2013-06-05
ES2314826T3 (es) 2009-03-16
PL2279672T3 (pl) 2021-09-13
US10426791B2 (en) 2019-10-01
ATE413816T1 (de) 2008-11-15
PL2279671T3 (pl) 2017-06-30
ES2757674T3 (es) 2020-04-29
ES2874273T3 (es) 2021-11-04
EP1927292A1 (en) 2008-06-04
SI1685763T2 (sl) 2013-08-30
JP2007538067A (ja) 2007-12-27
SI1927292T1 (sl) 2010-01-29
DK1685763T4 (da) 2013-08-05
EP2279671B1 (en) 2016-10-05
CY1110425T1 (el) 2015-04-29
DE602005010964D1 (de) 2008-12-24
JP2012087133A (ja) 2012-05-10
NZ551249A (en) 2011-04-29
ES2331935T3 (es) 2010-01-20
EP2266422A1 (en) 2010-12-29
CA2565421A1 (en) 2005-11-24
US20220125826A1 (en) 2022-04-28
EP2279672B1 (en) 2021-03-10
SI1685763T1 (sl) 2009-02-28
PT1685763E (pt) 2009-01-02
AU2005244321A1 (en) 2005-11-24
JP5705400B2 (ja) 2015-04-22
ATE440506T1 (de) 2009-09-15
DK1685763T3 (da) 2009-01-12
US20200023000A1 (en) 2020-01-23
EP1597978A1 (en) 2005-11-23
CN1964638B (zh) 2010-12-08
EP1679980B1 (en) 2016-05-04
US20180153923A1 (en) 2018-06-07
AU2010241530B2 (en) 2013-02-14
PL1685763T5 (pl) 2013-10-31
EP2279672A1 (en) 2011-02-02
DE602005016319D1 (de) 2009-10-08
CN102090560B (zh) 2013-11-13
PL1685763T3 (pl) 2009-03-31
RU2402929C2 (ru) 2010-11-10
US20130210763A1 (en) 2013-08-15
PL1927292T3 (pl) 2010-01-29
EP1685763B1 (en) 2008-11-12
HUE046219T2 (hu) 2020-02-28
EP1685763A1 (en) 2006-08-02
DK1927292T3 (da) 2009-12-21

Similar Documents

Publication Publication Date Title
BRPI0511133A (pt) uso de galacto-oligossacarìdeos e polifrutose
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
MX379353B (es) Compuesto de piperidina tipo quinoxalina sustituida y uso de los mismos.
ECSP088543A (es) Anticuerpos anti-ox40l y métodos que los utilizan
CR20150088A (es) Anticuerpos anti-notch1 nrr
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
CR11861A (es) Compuestos organicos
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
UY30610A1 (es) Moduladores de mglur5
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
CR10454A (es) Composiciones farmaceuticas novedosas de baja dosis que comprenden nimesulida , preparacion y uso de las mismas
MX2009010174A (es) Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos.
UY32520A (es) Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY30801A1 (es) Compuestos calciliticos
EA200901030A1 (ru) Антагонист хроменового рецептора s1p1
BRPI0813501A2 (pt) Compostos, compostos que influenciam sistemas vesiculares celulares, composições farmacêuticas e uso dos mesmos
BRPI0821160A2 (pt) Octahidroquinolizinas, composição farmacêutica contendo as mesmas e uso de ditos compostos
ITMI20041855A1 (it) Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.
HN2008000082A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparacion y aplicacion en terapeutica

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/733 (2006.01), A23L 29/244 (2016.01), A23L

B09B Patent application refused [chapter 9.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 29/244 (2016.01), A23L 29/30 (2016.01), A23L

B12B Appeal against refusal [chapter 12.2 patent gazette]